|Day Low/High||131.91 / 144.90|
|52 Wk Low/High||125.12 / 376.11|
It still takes a bit of guts and some nose holding to keep this stock on board in this environment.
For people willing to brave the waters, there are now quality names with distinguishing characteristics that look attractive.
As the year has been upended by the Russian invasion of Ukraine, this name has all of the hallmarks of a secular growth story.
CRWD reported Q4 results Wednesday, beating expectations.
The crisis in Ukraine underscores threats to the world and to companies big and small. Investors should take notice.
The shares plunged Friday following the company's latest earnings.
Thursday's gains evaporated overnight, and then some.
Thought the semiconductor shortage had already been severe? That's where the cards currently lie.
Are we calling the end of the attempted rally that started with that Monday, January 24th reversal? Not so fast my friends... not so fast.
The disappointing reality for swing traders is that there's no way to know when the selling in tech will subside.
Friday brings about data for December retail sales and industrial production, and the start of the fourth quarter earnings season as big banks start to report.
There are other areas to trade as well, but know what you are trying to accomplish.
The market may be preparing itself for a much tougher environment that if not met with the necessary level of finesse, could be somewhat lengthy.
I'm sure that those who invest in precious metals 100 years after my death will hold physical gold. Can anyone holding Bitcoin make a similar suggestion?
My opinion has long been that I must be invested in cybersecurity regardless of valuation as demand for these services may not dwindle in my lifetime.
Whether panicked sales over these past few days, especially Wednesday, prove to be either the 'fast' or 'smart' money remains to be seen.
This may still be a trade and not an investment.
Jerome Powell must be very worried about Omicron and the variant's ability to prolong inflation where it might have started to ebb.
Satya Nadella's decision to sell almost half his stake in Mr. Softee prompts a closer technical look at what may lie ahead for the tech giant's shares.
I wouldn't expect a lot in the way of economic shutdowns, at least not unless clear evidence presents that people are getting sicker from Omicron.
And I'll likely be legging in from the short side.
We're updating our bullish technical strategy for Zscaler stock.
Plus, an FDA advisory panel gives a unanimous boost to a Moderna booster shot and Boeing slumps on a negative news report.
The charts of the cloud security provider appear favorable.
In a real bear market, one that persists, volumes will dry up. Corrections are violent and volatile. That's where we are now.
Plus, Zscaler largely delivers for its owners with its latest results.
Will ZS go out on any kind of limb for the current full year? That's what will decide the overnight direction of the stock.